Literature DB >> 22914965

Inhibitory effects of baicalin on orthotopic xenografts of colorectal cancer cells that are deficient in a mismatch repair gene in nude mice.

Bo-Lin Yang1, Hong-Jin Chen, Yu-Gen Chen, Yun-Fei Gu, Shu-Peng Zhang, Qiu Lin, Yu Sun.   

Abstract

OBJECTIVE: The aim of this article is to study the inhibitory effects of baicalin on the growth and metastasis of orthotopic xenografts consisting of human HCT-116 colorectal cancer cells that are deficient in the mismatch repair gene hMLH1 in nude mice.
METHODS: A fluorescent orthotopic transplantation model of HCT-116 cells was established. The treatment groups were administered baicalin 50 mg/kg (G2), 100 mg/kg (G3), and 200 mg/kg (G4), and the negative control group (G1) was administered 5 % NaHCO₃. The volume and vascular density of the primary tumors, body weights, survival conditions, and death rates of the mice were analyzed.
RESULTS: On the 14th, 21st, and 28th days, tumor volume in the treatment groups was significantly smaller than that in the control group, and the differences were statistically significant. At the end of the experiment, the survival rate of the experimental animals in the G3 was significantly higher than that in the G1 and G4 (P < 0.05). There were no significant differences in both the weights and surface vascular densities of the primary tumor and the metastatic tumor among all groups.
CONCLUSION: Baicalin had a significant inhibitory effect on the growth of nude mouse orthotopic xenografts consisting of human HCT-116 colorectal tumor cells that are deficient in the mismatch repair gene hMLH1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914965     DOI: 10.1007/s00384-012-1562-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  15 in total

1.  A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.

Authors:  C P Carron; D M Meyer; J A Pegg; V W Engleman; M A Nickols; S L Settle; W F Westlin; P G Ruminski; G A Nickols
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

2.  Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.

Authors:  M F Acikalin; U Oner; I Topçu; B Yaşar; H Kiper; E Colak
Journal:  Dig Liver Dis       Date:  2004-12-09       Impact factor: 4.088

Review 3.  Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC).

Authors:  Annegret Müller; Richard Fishel
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

4.  A fluorescent orthotopic bone metastasis model of human prostate cancer.

Authors:  M Yang; P Jiang; F X Sun; S Hasegawa; E Baranov; T Chishima; H Shimada; A R Moossa; R M Hoffman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

5.  Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Authors:  John Burn; D Timothy Bishop; Jukka-Pekka Mecklin; Finlay Macrae; Gabriela Möslein; Sylviane Olschwang; Marie-Luise Bisgaard; Raj Ramesar; Diana Eccles; Eamonn R Maher; Lucio Bertario; Heikki J Jarvinen; Annika Lindblom; D Gareth Evans; Jan Lubinski; Patrick J Morrison; Judy W C Ho; Hans F A Vasen; Lucy Side; Huw J W Thomas; Rodney J Scott; Malcolm Dunlop; Gail Barker; Faye Elliott; Jeremy R Jass; Ricardo Fodde; Henry T Lynch; John C Mathers
Journal:  N Engl J Med       Date:  2008-12-11       Impact factor: 91.245

6.  A novel orthotopic mouse model of human anaplastic thyroid carcinoma.

Authors:  Carmelo Nucera; Matthew A Nehs; Michal Mekel; Xuefeng Zhang; Richard Hodin; Jack Lawler; Vânia Nose; Sareh Parangi
Journal:  Thyroid       Date:  2009-10       Impact factor: 6.568

7.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

8.  Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

Authors:  Richard F A Logan; Matthew J Grainge; Vic C Shepherd; Nicholas C Armitage; Kenneth R Muir
Journal:  Gastroenterology       Date:  2007-10-10       Impact factor: 22.682

Review 9.  Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages.

Authors:  M C Bibby
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

10.  A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR.

Authors:  Lucia Perez-Cabornero; Eladio Velasco; Mar Infante; David Sanz; Enrique Lastra; Lara Hernández; Cristina Miner; Mercedes Duran
Journal:  Eur J Cancer       Date:  2009-02-26       Impact factor: 9.162

View more
  1 in total

1.  Baicalin and its emerging antineoplastic effects in systemic malignancies besides colorectal carcinomas.

Authors:  Shailendra Kapoor
Journal:  Int J Colorectal Dis       Date:  2012-11-01       Impact factor: 2.571

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.